Nuclear Medicine Imaging Market Report, 2021 Share, Key Players, Segmentation Analysis, Business Growth and Forecast to 2027
In the last decade, there has been a major
evolution of hybrid systems due to technological breakthroughs in the field of
imaging. The use of integrated PET modalities is a significant advancement in
this area. The PET/CT modality has been so successful in terms of innovation
that major imaging system manufacturers no longer offer solo PET systems.
Furthermore, one of the key drivers for the market is the growth in the
occurrence of cancer and cardiac diseases. Nuclear medicine has a lot of
potential for treating cancer and heart disease. There is substantial evidence
that using nuclear imaging techniques to diagnose a tumor has a greater
influence on patient management in terms of tumor surveillance and treatment response.
Download Free Sample of this Report - https://univdatos.com/request_form/form/431
The COVID19 has resulted in a profound re-evaluation
of the advantages and costs of cancer care. The pandemic has been a devastating
disease worldwide. Although an important number of young healthy people have
been affected, elderly, comorbid and immunosuppressed patients have been
especially compromised. For instance, the
largest report up until September 30, 2020, came from the COVID-19 and Cancer
Consortium (CCC19), that reported 30-day all-cause mortality for 928 patients
from the United States, Canada, and Spain with laboratory confirmed SARS-CoV-2
and a diagnosis of invasive or hematologic malignancy between March 17, and
April 16, 2020. Of those receiving anticancer therapy, only 16% (38 patients)
had received immunotherapy, including immune checkpoint blockade (ICB),
allogeneic stem cell transplant, or adoptive cell therapy. The COVID-19 pandemic
has had a substantial impact on hospital resources around the world. This has
mostly been accomplished by drastically lowering in-patient and outpatient
treatment for various diseases, as well as instituting infection prevention and
control methods.
Request To Download Sample of this Strategic
Report - https://univdatos.com/request_form/form/431
Based on therapy, the market is
fragmented into monoclonal antibodies, vaccines, checkpoint inhibitors, cell
therapies, immune system modulators, adoptive cell transfer, cytokines, and
others. The monoclonal antibodies segment dominated the market in 2020 and
generated the total revenue of USD 31.79 billion. It is anticipated to maintain
its dominance during the forecast period owing to the diverse
set of clinically relevant mechanisms of action like directly targeting tumor
cells while simultaneously promoting the induction of long-lasting anti-tumor
immune responses. However,
the bre-ast cancer segment is expected to
witness highest CAGR during the forecast period.
The various
application wherein cancer Immunotherapy is utilized includes SPECT Imaging
Systems, PET Imaging Systems, and Planar Scintigraphy Imaging SystemA. In 2020, SPECT imaging systems segment accounted
for a maximum market revenue share of X% and is expected to remain dominant
during the analyzed period.
Request
for full report - https://univdatos.com/request_form/form/431
Based on end-user, the market is
fragmented into hospitals, imaging centers, academic & research centers,
and others. The hospitals segment dominated the market in 2020
and generated the total revenue of USD X billion. It is anticipated to maintain
its dominance during the forecast period. Moreover, the segment is also expected to
witness highest CAGR during the analyzed period.
Additionally, the report provides detailed
initiatives that are being taken in the field of Nuclear Medicine Imaging. The
market is classified into distinct regions North
America (United States, Canada, and the Rest of North America), Europe
(Germany, France, Italy, Spain, United Kingdom and Rest of Europe),
Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been
conducted. North America dominated the market and generated revenue of USD X billion
in 2020 owing to the increasing cancer incidence and higher healthcare spending. At the same time, Asia-Pacific is anticipated to grow at the
highest CAGR of 11.93% during the forecast period.
Request
for Sample of the report browse through - https://univdatos.com/request_form/form/431
Siemens Healthineers, GE Healthcare, Philips, Digirad Corporation,
Mediso Medical Imaging Systems, Positron Corporation, Cardinal Health Inc.,
Bracco Imaging SpA, Hitachi Medical Corporation, Canon Medical Systems Corporation
are some of the
prominent players operating in the global Nuclear Medicine Imaging market. Several M&A’s along with partnerships have been undertaken by
these players to develop Nuclear Medicine Imaging.
Global Nuclear Medicine Imaging Market Segmentation
Market Insight, by Product
• SPECT
Imaging Systems
• Hybrid
SPECT Imaging Systems
• Standalone
SPECT Imaging Systems
• PET
Imaging Systems
• Planar
Scintigraphy Imaging SystemsA
Market Insight, by Application
• Oncology
• Cardiology
• Neurology
• Others
Market Insight, by End-User
• Hospitals
• Imaging
Centers
• Academic
& Research Centers
• Others
Market Insight, by Region
•
North America
o United
States
o Canada
•
Europe
o
France
o
Germany
o
Italy
o
Spain
o
United Kingdom
o
Rest of Europe
•
Asia-Pacific
o
China
o
Japan
o
India
o
Rest of Asia-Pacific
•
Rest of World
Top Company Profiles
·
Siemens Healthineers
·
GE Healthcare
·
Philips
·
Digirad
Corporation
·
Mediso
Medical Imaging Systems
·
Positron
Corporation
·
Cardinal
Health Inc.
·
Bracco
Imaging SpA
·
Hitachi
Medical Corporation
·
Canon Medical Systems Corporation
Labels: Nuclear Medicine Imaging Market
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home